In patients with early-stage breast cancer, neoadjuvant chemotherapy (NAC) is a common treatment to reduce tumor size before surgery. A team has found dynamic diffuse optical tomography (DDOT) can detect if a tumor has responded to chemotherapy within two weeks of initial treatment—potentially life-saving information for patients. ​​​​​​​

Pairing ultrasound with a blood test to detect high alpha fetoprotein (AFP) levels demonstrated up to a 40 percent improvement in detecting early-stage liver cancer, according to new research published in the journal Gastroenterology.

Research from two independent clinical trials demonstrated the ability of new drugs in treating the most challenging prostate cancers that reject standard hormonal therapy, the New York Times reports.

The U.S. Food and Drug Administration (FDA) announced it has approved domestic production of technetium-99m (Tc-99m), the most commonly used radioactive imaging isotopes.

Pennsylvania researchers discovered opposed-phase MRI imaging is less accurate in detecting treated spinal metastases compared to those lesions that are untreated.

Breast cancer is the most common form of cancer among women. And a new study finds injecting oxygen-filled microbubbles into breast cancer makes tumors three times more responsive to radiation treatment, according to an International Journal of Radiation Oncology study.

High rates of incidental findings, limited risk-reward outcomes and unnecessary emotional stress suggest to one group of authors that lung cancer screening efforts need to be refined and the risk and benefits clearly communicated to better screen high-risk patients.

Researchers from Georgia have successfully stifled the production of a chemical sent by aggressive cancers to bone marrow allowing them to thrive in the body.